Low Level Laser and Canine Cancer

Diseases, proactive care, geriatric issues, etc.

Moderator: Moderator Pack

Low Level Laser and Canine Cancer

Postby Doc E » Tue Jul 29, 2014 3:44 pm

Palliative Cancer Care Using Frequency-Specific Low Level Laser
Four Case Reports
AHVMA Journal [American Holistic Veterinary Medical Association]
Volume 35; Spring 2014; pp. 28-34
Jeff Grognet, DVM, BSc(Agr) and Louise Janes, BSc(Agr), DVM
From British Columbia, Canada “Drs. Jeff Grognet and Louise Janes are private practice veterinarians, with no paid connection to the Erchonia Corporation that manufactures the laser device
employed in this case report.”

This article presents four clinical cases based upon the teachings of veterinarian Dr. William Inman. Dr. Inman’s teachings include the perspective that the entire body is integrated physiologically through a series of specific frequencies, and that these frequencies are critical for cellular communication and homeostasis. Dysfunction and disease are consequences of disruptions of these cellular communications.
Specifically applied frequencies through the modality of low level laser therapy, as determined by logarithmic chaos conversion factor, can help restore proper intercellular communication and improve systemic physiology. Dr. Inman (and the authors of this study) believe that application of the necessary frequencies “appears to be the key to re-establishing the communication needed to promote healing in complex conditions such as neoplasia.” The Erchonia laser device allows the programing of 50,000 frequencies in fractions (XX,XXX.XX). This article supports this perspective.

Four cases of cytologically diagnosed, histologically diagnosed, or presumed
malignant neoplasia managed with frequency-specific low level laser therapy in
dogs are described.
In each of these cases, the therapy resulted in temporary tumor regression and
improvement in clinical signs associated with the cancer.
Specific laser frequencies along with chaos conversion factor frequencies for third (and fourth) bodies were utilized to manage four cancer patients [dogs] with a class two laser.
1) “Frequency-specific low level laser therapy (FSLLLT) is currently being used to manage a myriad of disease conditions in companion animals.”
2) “The potential of FSLLLT can be fully realized with the use of the Erchonia
base station laser.”
3) This study used an Erchonia Base Station class II laser. “The laser utilized
was designed to re-establish communication systems of the body using the
elements that emulate the energy type (photonic light), the wavelength (635 and 405 nm), the energy level (5 milliwatts), as well as the frequencies that are inherent to all biological systems.”
4) The Erchonia “laser depends on the delivery of specific frequencies of light (in the correct form) to elicit healing.”
5) “FSLLLT enhances the body’s ability to solve its own problems by putting the
cells of the body back into communication with one another.”

6) In this study, 6 laser heads with 2 diodes each were used:
Head #1: 635 nm (red), 5 mw
635 nm (red), 5 mw
Head #2: 635 nm (red), 7.5 mw
635 nm (red), 7.5 mw
Head #3: 635 nm (red), 5 mw
405 nm (violet), 5 mw
7) Each of the cases presented chronicles the animals clinical status, function
level, symptoms, signs, and diagnostic findings, initially and at follow-up visits until death. The exact laser frequencies, locations, and treatment intervals are
presented. The presented outcomes suggest significantly extended life and
improvement in function and quality of life.
Case #1: Retroperitoneal Soft Tissue Sarcoma, 9-year-old, castrated male
Case #2: Lymphosarcoma, 15-year-old neutered, male German
shorthaired pointer
Case #3: Myxosarcoma, 11-year-old neutered, female Labrador retriever
Case #4: Large, Non-cleaved Cell Lymphosarcoma, 14-year-old castrated
male Border collie
8) “Historically, laser use in patients with cancer has been dissuaded because of the belief that it augments cancer cell growth. Though this may be true for the more powerful units, very weak units, such as the Erchonia laser, are being used for successful palliation of cancer in companion animals.”
9) “In the cancer patient cases presented in this article, FSLLLT extended the
patients’ lifespan, with good quality of life, beyond what would have been expected had FSLLLT not been implemented for the presenting clinical proble.

Doc E
HR UH MHR WR SR Casey RIP my friend :(
HRCH HR UH Tucker 1420 HR Ch. points :D
HRCH HR UH Weezle 265 HR Ch. points :)
User avatar
Doc E
Champion Poster
Champion Poster
Posts: 2297
Joined: Tue Sep 03, 2002 9:19 am
Location: N.E. WA state

Return to Healthcare

Who is online

Users browsing this forum: No registered users and 1 guest